Sio Capital Management’s RVL Pharmaceuticals plc Ordinary Shares RVLP Stock Holding History

Sio Capital Management’s Portfolio RVLP Stock Details RVLP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-519,039	Closed	-$1.69M	–	99
2021 Q1	$1.69M	Buy	+519,039	New	+$2.13M	0.34%	66
2020 Q2	–	Sell	-575,000	Closed	-$1.83M	–	95
2020 Q1	$1.83M	Buy	+575,000	New	+$3.06M	0.61%	35
2019 Q2	–	Sell	-346,410	Closed	-$1.25M	–	92
2019 Q1	$1.25M	Hold	346,410	–	–	0.34%	61
2018 Q4	$2.69M	Buy	+346,410	New	+$2.77M	0.98%	41

Other funds holding RVLP

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Rovida Advisors Fort Lauderdale, Florida $116M AUM 12.52% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Sio Capital Management's RVLP Position: Q2 2021 in Review

Sio Capital Management sold out of RVL Pharmaceuticals plc Ordinary Shares (RVLP) in Q2 2021, closing a stake of 519,039 shares — an estimated $1.69M sold.

Sio Capital Management first reported a position in RVLP in Q4 2018 and held it in 4 quarters. The position peaked at $2.69M in Q4 2018. 46 funds tracked by Wall St. Rank hold RVLP as of Q2 2021.

Sio Capital Management reported no remaining RVL Pharmaceuticals plc Ordinary Shares position as of Q2 2021 after selling out during the quarter.
Sio Capital Management sold 519,039 RVL Pharmaceuticals plc Ordinary Shares shares in Q2 2021, an estimated $1.69M.
Sio Capital Management first reported a position in RVL Pharmaceuticals plc Ordinary Shares in Q4 2018 and held it in 4 quarters.
Sio Capital Management's RVL Pharmaceuticals plc Ordinary Shares position peaked at $2.69M in Q4 2018.
46 funds tracked by Wall St. Rank held RVL Pharmaceuticals plc Ordinary Shares as of Q2 2021.

Based on Sio Capital Management's 13F filing for Q2 2021, filed 16 Aug 2021.